GlaxoSmithKline PLC ADR (GSK) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL

Exchange: NYSE

Key Metrics

• Price: $58.06
• Market Cap: $119.48B
• P/E Ratio: 15.88
• EPS: $3.75
• Dividend Yield: 0.03%
• 52-Week High: $61.21
• 52-Week Low: $31.14

Market Sentiment

GlaxoSmithKline PLC ADR currently has a Bullish sentiment score of 0.41.

About GlaxoSmithKline PLC ADR

GlaxoSmithKline PLC (GSK) is a prominent global biopharmaceutical company headquartered in Brentford, UK, dedicated to improving health outcomes through its innovative pharmaceuticals, vaccines, and consumer healthcare products. With a focus on robust research and development, GSK aims to tackle significant global health challenges while maintaining a diverse product portfolio across multiple therapeutic areas. The company’s strategic initiatives and commitment to advancing medical science po...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for GlaxoSmithKline PLC ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is GSK's current dividend yield?

GlaxoSmithKline PLC ADR (GSK) has a current dividend yield of 0.03%.

Does GSK pay dividends?

Yes, GlaxoSmithKline PLC ADR pays dividends with a current yield of 0.03%.

What is GSK's P/E ratio?

GlaxoSmithKline PLC ADR has a price-to-earnings (P/E) ratio of 15.88.

What is GSK's market cap?

GlaxoSmithKline PLC ADR (GSK) has a market capitalization of $119.48B with a current stock price of $58.06.